Quick search
Popular searches:
A new resource for personnalized medicine and artificial intelligence research in Québec Montréal, May 14th, 2024 – Génome Québec and the CHU Sainte-Justine are proud to announce the official launch of the Québec Genomic Data Centre (CQDG), a brand-new platform designed for harmonizing and disseminating genomic data to researchers. The CQDG will host the data…
Montréal, May 3rd, 2024 – It is with great pleasure that Génome Québec and Cystic Fibrosis Canada join forces to create a new funding program to support omics research on cystic fibrosis. With the aim of accelerating therapeutic innovation for the treatment of this rare disease, this program will also be aligned with the objectives…
Montréal, March 15, 2024 – It is with great enthusiasm that Génome Québec, Ataxia Canada, and Muscular Dystrophy Canada announced today, during a webinar, the winners of the Innovative Therapies for Hereditary Ataxias competition. This initiative was created to encourage the discovery and development of new therapies and mobilize the research ecosystem. The total investment,…
During this webinar, Ataxia Canada, Génome Québec and Muscular Dystrophy Canada will unveil the projects funded in the “Innovative Therapies for Hereditary Ataxias” competition. When: March 15, 2024, 12-2PM EDT. Where: virtual (Zoom) Language: bilingual virtual event To register: https://us02web.zoom.us/j/86768351570
The CARTaGENE/Génome Québec webinar is now available online! The presentations covered a wide range of topics, from genealogy to structural variants. These topics were covered by projects benefiting from the whole-genome sequencing of CARTaGENE, Québec’s largest population-based cohort. 🧬 This is a possible step towards integrating genomics into the healthcare system, potentially facilitating access to…
By popular demand, presentations are now available! This two-day event on the progress and challenges of implementing genomic medicine in healthcare took place on November 7 and 8, 2023. Experts and key players in the field discussed the technologies, applications, ethics and social impacts of practicing genomic medicine. The Rendez-vous Génome Québec in pictures
Montréal, December 12, 2023 — Génome Québec is particularly proud of the performance of Québec teams in a pan-Canadian competition. Over $23 million will be invested in genomics in Québec, including $5.4 million through Génome Québec. In fact, 49% of the available Canadian envelope was allocated to Québec projects. These investments will accelerate the commercialization…
Linearis Labs Inc (“Linearis”), an innovative company at the intersection of AI and biomarker analysis, announces today the inauguration of its new laboratory facilities at a site formerly occupied by Medicago Inc (“Medicago”). Following the announcement of the cessation of their operations after 26 years, Linearis acquired over 650 scientific instruments and hired some of…
Montréal, November 20, 2023 —Génome Québec is proud to announce the six research teams that have won major funding under the Genomic Solutions for the Identification, Characterization and Monitoring of Antimicrobial Resistance and Emerging Pathogens program. The total investment, including that of public and private partners, represents over $4.5 million, and will support the development…
Not a little proud of our fine team at the Centre d’expertise et de services Génome Québec! Today we’re celebrating a major milestone: the 400,000th sample genotyped and a billion genotypes analyzed using Illumina’s Infinimum technology. We are the first Canadian laboratory to have achieved such a feat.